These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30333522)

  • 1. Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients.
    Rausell D; García-Blanco A; Correcher P; Vitoria I; Vento M; Cháfer-Pericás C
    Pediatr Res; 2019 Jan; 85(2):242-250. PubMed ID: 30333522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
    Moraes TB; Jacques CE; Rosa AP; Dalazen GR; Terra M; Coelho JG; Dutra-Filho CS
    Cell Mol Neurobiol; 2013 Mar; 33(2):253-60. PubMed ID: 23232760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.
    Imperlini E; Orrù S; Corbo C; Daniele A; Salvatore F
    J Neurochem; 2014 Jun; 129(6):1002-12. PubMed ID: 24548049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation.
    Wyse ATS; Dos Santos TM; Seminotti B; Leipnitz G
    Mol Neurobiol; 2021 Jun; 58(6):2897-2909. PubMed ID: 33550493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Barden AT; Biancini GB; Vargas PR; de Souza CF; Netto C; Wajner M; Vargas CR
    Int J Dev Neurosci; 2009 May; 27(3):243-7. PubMed ID: 19429389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental hyperphenylalaninemia provokes oxidative stress in rat brain.
    Kienzle Hagen ME; Pederzolli CD; Sgaravatti AM; Bridi R; Wajner M; Wannmacher CM; Wyse AT; Dutra-Filho CS
    Biochim Biophys Acta; 2002 Apr; 1586(3):344-52. PubMed ID: 11997085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter disturbances in phenylketonuria: Possible underlying mechanisms.
    Ferreira BK; Rodrigues MT; Streck EL; Ferreira GC; Schuck PF
    J Neurosci Res; 2021 Jan; 99(1):349-360. PubMed ID: 32141105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.
    Kumru B; Kaplan DS; Oztürk Hismi B; Celik H
    Cell Mol Neurobiol; 2018 Jul; 38(5):1033-1038. PubMed ID: 29285660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C.
    Martinez-Cruz F; Pozo D; Osuna C; Espinar A; Marchante C; Guerrero JM
    J Neurosci Res; 2002 Aug; 69(4):550-8. PubMed ID: 12210848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.
    Bortoluzzi VT; Dutra Filho CS; Wannmacher CMD
    Metab Brain Dis; 2021 Apr; 36(4):523-543. PubMed ID: 33580861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant treatment strategies for hyperphenylalaninemia.
    Mazzola PN; Karikas GA; Schulpis KH; Dutra-Filho CS
    Metab Brain Dis; 2013 Dec; 28(4):541-50. PubMed ID: 23657560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological deficits in early treated phenylketonuric children.
    Pennington BF; van Doorninck WJ; McCabe LL; McCabe ER
    Am J Ment Defic; 1985 Mar; 89(5):467-74. PubMed ID: 3993693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats.
    Berti SL; Nasi GM; Garcia C; Castro FL; Nunes ML; Rojas DB; Moraes TB; Dutra-Filho CS; Wannmacher CM
    Metab Brain Dis; 2012 Mar; 27(1):79-89. PubMed ID: 22101931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system].
    Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J
    Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
    Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
    Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in phenylketonuric patients.
    Vargas CR; Wajner M; Sitta A
    Mol Genet Metab; 2011; 104 Suppl():S97-9. PubMed ID: 21813309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.